"10.1371_journal.pone.0043813","plos one","2012-09-06T00:00:00Z","Tomás Maira-Litrán; Leticia V Bentancor; Cagla Bozkurt-Guzel; Jennifer M O'Malley; Colette Cywes-Bentley; Gerald B Pier","Channing Laboratory, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts, United States of America","Conceived and designed the experiments: TML LVB GBP. Performed the experiments: TML LVB CBG JMO CCB. Analyzed the data: TML LVB GBP. Wrote the paper: TML GBP.","Tomás Maira-Litrán (TML) and Gerald B. Pier (GBP) are inventors of Intellectual Property (IP) (PNAG Vaccine and human monoclonal antibody to PNAG) that is licensed by Brigham and Womens Hospital (BWH) to Alopexx Vaccines LLC, and Alopexx Pharmaceuticals LLC, companies in which GBP also owns equity. As inventors of the IP, they also have the right to receive a share of licensing related income (royalties, fees) through BWH from Alopexx Pharmaceuticals and Alopexx Vaccines. Their interests were reviewed and are managed by the BWH and Partners Healthcare in accordance with their conflict of interest policies. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","09","Tomás Maira-Litrán","TML",6,TRUE,3,5,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
